This Multiple Myeloma Awareness Month, Dr Brid Seoighe, medical director at Johnson & Johnson Innovative Medicine Ireland, ...

Spherix Global Insights' Q1 2026 update of RealTime Dynamix(TM): Multiple Myeloma findings point to a clear inflection in treatment strategy, as physicians grow increasingly confident in CAR-T therapy ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition. Following her dream wedding in Malta, the Minneapolis native faced a ...

The approval was supported by data from the ongoing Phase III MajesTEC-3 study.

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

Luciano Costa, MD, PhD, discusses the considerations for managing infection risk with bispecific antibodies in multiple ...

The recent FDA approval of teclistamab (Tecvayli) and daratumumab and hyaluronidase-fihj (Darzelex Faspro) marks a major shift in the treatment paradigm, moving powerful bispecifi ...

Johnson & Johnson’s standout trial results for its Tecvayli and Darzalex Faspro pairing in previously treated relapsed or refractory multiple myeloma have earned the company the third ultra-spe | FDA ...

How Does Multiple Myeloma Impact the Kidneys? Multiple myeloma is a cancer of plasma cells, a type of immune cell found in bone marrow. Healthy plasma cells make proteins called antibodies to fight ...

Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...

Staging is when a system is used to identify and describe how far a cancer has spread in your body. Knowing the stage of your multiple myeloma helps your physicians predict which treatments are most ...